Package 30142-963-14

{"route": ["ORAL"], "spl_id": "68444eae-5f25-4a1c-bcde-a6bab50377af", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["9D2RTI9KYH", "495W7451VQ"], "rxcui": ["1099074"], "spl_set_id": ["8f7200ff-3e4d-414a-a1f9-fe8daac67cb1"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Kroger Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (30142-963-14)  / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "30142-963-14", "marketing_start_date": "20220523"}, {"sample": false, "description": "2 BLISTER PACK in 1 CARTON (30142-963-28)  / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "30142-963-28", "marketing_start_date": "20220523"}], "brand_name": "GUAIFENESIN AND DEXTROMETHORPHAN HBR", "product_id": "30142-963_68444eae-5f25-4a1c-bcde-a6bab50377af", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]"], "product_ndc": "30142-963", "generic_name": "Guaifenesin and Dextromethorphan HBr", "labeler_name": "Kroger Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "GUAIFENESIN AND DEXTROMETHORPHAN HBR", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "60 mg/1"}, {"name": "GUAIFENESIN", "strength": "1200 mg/1"}], "application_number": "ANDA214781", "marketing_category": "ANDA", "marketing_start_date": "20220523", "listing_expiration_date": "20261231"}